Literature DB >> 29187425

MiRNA-210: A Current Overview.

Alberto Bavelloni1, Giulia Ramazzotti2, Alessandro Poli3,4, Manuela Piazzi1,5, Enrico Focaccia1,5, William Blalock6,5, Irene Faenza7.   

Abstract

microRNAs (miRNAs) are a group of highly conserved small non-coding RNAs that were found to enhance mRNA degradation or inhibit post-transcriptional translation. Accumulating evidence indicates that miRNAs contribute to tumorigenesis and cancer metastasis. microRNA-210 has been largely studied in the past several years and has been identified as a major miRNA induced under hypoxia. A variety of miR-210 targets have been identified pointing to its role, not only in mitochondrial metabolism, but also in angiogenesis, the DNA damage response, cell proliferation, and apoptosis. Based on earlier research findings, this review aims to provide a current overview on the involvement of miRNA-210 in biological processes and diseases. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  cancer; disease; hypoxia; miR-210; microRNA; review

Mesh:

Substances:

Year:  2017        PMID: 29187425     DOI: 10.21873/anticanres.12107

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  78 in total

1.  Targeted Degradation of a Hypoxia-Associated Non-coding RNA Enhances the Selectivity of a Small Molecule Interacting with RNA.

Authors:  Matthew G Costales; Blessy Suresh; Kamalakannan Vishnu; Matthew D Disney
Journal:  Cell Chem Biol       Date:  2019-05-23       Impact factor: 8.116

2.  Circulating microRNA plasma profile in MuSK+ myasthenia gravis.

Authors:  Liis Sabre; Jeffrey T Guptill; Melissa Russo; Vern C Juel; Janice M Massey; James F Howard; Lisa D Hobson-Webb; Anna Rostedt Punga
Journal:  J Neuroimmunol       Date:  2018-10-06       Impact factor: 3.478

3.  Integrated analysis of hypoxia-induced miR-210 signature as a potential prognostic biomarker of hepatocellular carcinoma: a study based on The Cancer Genome Atlas.

Authors:  Yi Dai; Ji-Liang Shen; Xue-Yong Zheng; Tian-Yu Lin; Hai-Tao Yu
Journal:  J Zhejiang Univ Sci B       Date:  2019 Nov.       Impact factor: 3.066

Review 4.  In Vitro Innovation of Tendon Tissue Engineering Strategies.

Authors:  Maria Rita Citeroni; Maria Camilla Ciardulli; Valentina Russo; Giovanna Della Porta; Annunziata Mauro; Mohammad El Khatib; Miriam Di Mattia; Devis Galesso; Carlo Barbera; Nicholas R Forsyth; Nicola Maffulli; Barbara Barboni
Journal:  Int J Mol Sci       Date:  2020-09-14       Impact factor: 5.923

5.  Exosomal microRNA-210 is a potentially non-invasive biomarker for the diagnosis and prognosis of glioma.

Authors:  Fengming Lan; Xiao Yue; Tingyi Xia
Journal:  Oncol Lett       Date:  2020-01-07       Impact factor: 2.967

6.  MiR-210 Is Overexpressed in Tumor-infiltrating Plasma Cells in Triple-negative Breast Cancer.

Authors:  Isabelle Bar; Ivan Theate; Sandy Haussy; Gabriela Beniuga; Javier Carrasco; Jean-Luc Canon; Paul Delrée; Ahmad Merhi
Journal:  J Histochem Cytochem       Date:  2019-12-01       Impact factor: 2.479

7.  Deletion of hypoxia-responsive microRNA-210 results in a sex-specific decrease in nephron number.

Authors:  Shelby L Hemker; Débora M Cerqueira; Andrew J Bodnar; Kasey R Cargill; Andrew Clugston; Melissa J Anslow; Sunder Sims-Lucas; Dennis Kostka; Jacqueline Ho
Journal:  FASEB J       Date:  2020-03-05       Impact factor: 5.191

8.  Long-term high altitude hypoxia during gestation suppresses large conductance Ca2+ -activated K+ channel function in uterine arteries: a causal role for microRNA-210.

Authors:  Xiang-Qun Hu; Chiranjib Dasgupta; Jeffery Xiao; Shumei Yang; Lubo Zhang
Journal:  J Physiol       Date:  2018-07-01       Impact factor: 5.182

9.  HIF-1α and miR-210 differential and lineage-specific expression in systemic lupus erythematosus.

Authors:  Barry Garchow; Yvan Maque Acosta; Marianthi Kiriakidou
Journal:  Mol Immunol       Date:  2021-02-28       Impact factor: 4.407

Review 10.  Potential Therapeutic Effects of Melatonin Mediate via miRNAs in Cancer.

Authors:  Pirouz Pourmohammad; Nazila Fathi Maroufi; Mohsen Rashidi; Vahid Vahedian; Farhad Pouremamali; Yousef Faridvand; Mahsa Ghaffari-Novin; Alireza Isazadeh; Saba Hajazimian; Hamid Reza Nejabati; Mohammad Nouri
Journal:  Biochem Genet       Date:  2021-06-28       Impact factor: 1.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.